Connection

GREG CUNY to Staphylococcus aureus

This is a "connection" page, showing publications GREG CUNY has written about Staphylococcus aureus.
Connection Strength

0.216
  1. Development of improved inhibitors of wall teichoic acid biosynthesis with potent activity against Staphylococcus aureus. Bioorg Med Chem Lett. 2010 Mar 01; 20(5):1767-70.
    View in: PubMed
    Score: 0.066
  2. Biological properties of novel antistaphylococcal quinoline-indole agents. Antimicrob Agents Chemother. 2003 Feb; 47(2):458-66.
    View in: PubMed
    Score: 0.041
  3. Potent in vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)tetrahydroquinoline derivatives. Bioorg Med Chem Lett. 2002 Jan 21; 12(2):129-32.
    View in: PubMed
    Score: 0.038
  4. The Enzymatic Activity of Inosine 5'-Monophosphate Dehydrogenase May Not Be a Vulnerable Target for Staphylococcus aureus Infections. ACS Infect Dis. 2021 11 12; 7(11):3062-3076.
    View in: PubMed
    Score: 0.037
  5. Potent in vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)quinoline derivatives. Bioorg Med Chem Lett. 2000 Dec 04; 10(23):2675-8.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.